John C.K. Milligan's most recent trade in TherapeuticsMD Inc was a trade of 103,500 Common Stock done . Disclosure was reported to the exchange on May 10, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 1,796,955 (0%) | 0% | - | Common Stock | |
TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 103,500 | 207,000 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | John C.K. Milligan | Secretary/CEO of subsidiary | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 10 May 2021 | 44,252 | 1,752,703 (0%) | 0% | 1.0 | 46,022 | Common Stock |
TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 434,814 | 0 (0%) | 0% | 0 | Common Stock | |
TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | 04 Mar 2021 | 179,000 | 1,723,419 (0%) | 0% | 0.2 | 43,748 | Common Stock | |
TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | 04 Mar 2021 | 179,000 | 0 | - | - | Warrant (right to buy) | ||
TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. | 04 Mar 2021 | 29,964 | 1,693,455 (0%) | 0% | 1.5 | 43,747 | Common Stock |
TherapeuticsMD Inc | John C.K. Milligan | President/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 360,000 | 360,000 | - | - | Restricted Stock Units |